SCHEMBL6207048

SCHEMBL6207048

NC(=O)C[C@H](C(=O)c1ncco1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.48
CES1 P23141 4/20 0.46
FAAH O00519 5/20 0.45
NCEH1 Q6PIU2 1/20 0.45
HDAC3 O15379 5/20 0.40
HDAC4 P56524 5/20 0.40
HDAC1 Q13547 5/20 0.40
HDAC7 Q8WUI4 5/20 0.40
HDAC2 Q92769 5/20 0.40
HDAC10 Q969S8 5/20 0.40
HDAC11 Q96DB2 5/20 0.40
HDAC8 Q9BY41 5/20 0.40
HDAC6 Q9UBN7 5/20 0.40
HDAC9 Q9UKV0 5/20 0.40
HDAC5 Q9UQL6 5/20 0.40
EPHX1 P07099 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.38
NR3C2 P08235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472186 0.80 KMT2A (0.38) CYP2C19CES1FAAH
SCHEMBL24095868 0.76 CES1 (0.36) CYP2C19CES1FAAHNCEH1HDAC3
SCHEMBL30511427 0.76 CES1 (0.36) CYP2C19CES1FAAHNCEH1HDAC3
SCHEMBL7038216 0.74 L3MBTL1 (0.52) CYP2C19CES1EPHX1HTTLMNA
SCHEMBL5955880 0.72 FAAH (0.54) CES1FAAHNCEH1HDAC3HDAC4
SCHEMBL1520271 0.71 GAA (0.54) CYP2C19EPHX1GAAHTTLMNA
SCHEMBL3353282 0.71 EPHX1 (0.63) CYP2C19EPHX1GAAHTTLMNA
Hydrochloric Acid SCHEMBL3353959 0.70 EPHX1 (0.61) CYP2C19EPHX1GAAHTTLMNA
SCHEMBL13544797 0.69 EPHX1 (0.50) CYP2C19EPHX1GAAHTTLMNA
SCHEMBL30281332 0.69 CES1 (0.45) CES1FAAHNCEH1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed